Brazil to integrate injectable Cabotegravir into SUS for HIV prevention by year-end

The Brazilian Ministry of Health is preparing to incorporate long-acting injectable Cabotegravir into the Unified Health System (SUS) by late 2026. This prophylactic treatment, administered every two months, represents a shift in HIV prevention strategy, though final implementation timelines remain subject to procurement and distribution logistics.